| Horus Pharma Suisse SA - Latazed 50 ug/ml, collyre en solution |
| 69656 | | 01 | | Latazed 50 ug/ml | | collyre en solution | | S01EE01 | | Latanoprost | | 31.03.2025 | | |
|
| Zusammensetzung |
| latanoprostum 0.05 mg, macrogolglyceroli hydroxystearas 25 mg, natrii chloridum, dinatrii edetas, natrii dihydrogenophosphas dihydricus et dinatrii phosphas corresp. phosphas 6.35 mg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| collyre en solution | | | | | | Wirkstoffe | Stärke |
|---|
| Latanoprost | 0.05 mg/ml |
| | | | Hilfsstoffe | Stärke |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Dinatrii Edetas | | | Dinatrium Phosphat | | | Macrogolglyceroli Hydroxystearas | 25 mg/ml | | Natrium Chlorid | | | Natrium Dihydrogenophosphat Dihydrat | |
|
|
| Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 2.5 ml | PA | PA | B | | Nein | | 002 | 5 ml | PA | PA | B | | Nein | | 003 | 3 x 2.5 ml | PA | PA | B | | Nein | | 004 | 3 x 5 ml | PA | PA | B | | Nein |
|
